European Biosimilars Market Outlook


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various issues surrounding biosimilars, key drivers, restraints and challenges facing market participants. In addition, it includes a segment-wise and country-wise market opportunity analysis followed by recommendations to market participants.

Table of Contents

European Biosimilars Market Outlook, Executive SummaryExecutive SummaryExecutive SummaryEuropean Biosimilars Market Outlook, Glossary of Terms and Research MethodologyGlossary of TermsAbbreviationsResearch MethodologyResearch MethodologyEuropean Biosimilars Market Outlook, European Biosimilars MarketIntroduction DefinitionRole of Biosimilars in the European UnionEvolution of the Regulatory Pathway in the EUKey Issues Surrounding Biosimilars in the European UnionScope and SegmentationMarket OverviewMarket Engineering ResearchMarket Engineering MeasurementsIndustry ChallengesMarket DriversMarket RestraintsCompetitive StructureEuropean Biosimilars Market Outlook, Competitor AnalysisKey European PlayersSandozBioceuticalsBiogeneriX AGBiopartners GmbHTevaKey Indian PlayersDr. Reddy's Laboratories LimitedIntas BioPharmaRanbaxy Laboratories LimitedReliance Life SciencesWockhardtEuropean Biosimilars Market Outlook, Country-wise Opportunity AnalysisAnalysis by GeographyFranceGermanyItalySpainThe United KingdomEuropean Biosimilars Market Outlook, Segment-wise Opportunity AnalysisErythropoeitinsMarket OverviewGranulocyte Colony Stimulating FactorsMarket OverviewHuman Growth HormonesMarket OverviewInsulin and AnalogsMarket OverviewInterferonsMarket OverviewEuropean Biosimilars Market Outlook, Strategic RecommendationsKey Success FactorsCritical Success FactorsEuropean Biosimilars Market Outlook, Database of Key Industry ParticipantsDatabase of Market ParticipantsDKIPEuropean Biosimilars Market Outlook, Decision Support DatabasesKey DatabasesNumber of Biotech CompaniesNumber of Patents Applied to the European Patent OfficeGovernment R&D Investment in BiotechnologyPer cent Government Biotech R&D InvestmentVenture Capital Investment in Biotechnology

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.